v3.23.1
Consolidated Statement of Shareholders' Equity - USD ($)
$ in Thousands
Total
IPO
Series A preferred
Series A preferred
Series A preferred
Ordinary shares
Ordinary shares
IPO
Additional paid-in capital
Additional paid-in capital
IPO
Accumulated other comprehensive (loss) income
Accumulated deficit
Preferred stock, beginning balance (in shares) at Jan. 29, 2021       0            
Beginning balance at Jan. 29, 2021 $ (4,651)     $ 0 $ 21   $ 0   $ (90) $ (4,582)
Ordinary shares, beginning balance (in shares) at Jan. 29, 2021         7,500,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Shares issued (in shares)       22,272,721   18,975,000        
Shares issued   $ 344,136 $ 241,597 $ 241,597   $ 54   $ 344,082    
Issuance of Series A convertible preferred shares upon conversion of debt (in shares)       568,181            
Issuance of Series A convertible preferred shares upon conversion of debt 6,250     $ 6,250            
Acquisition of Centessa Subsidiaries (in shares)         40,308,079          
Acquisition of Centessa Subsidiaries, net 262,686       $ 111   262,575      
Forgiveness of convertible term loan 6,199           6,199      
Conversion of Series A convertible preferred shares into ordinary shares (in shares)       (22,840,902) 22,840,902          
Conversion of Series A convertible preferred shares into ordinary shares 0     $ (247,847) $ 65   247,782      
Stock option exercises (in shares)         133,389          
Stock option exercises 779           779      
Share-based compensation expense 14,851           14,851      
Vesting of ordinary shares (in shares)         230,858          
Vesting of ordinary shares 0       $ 1   (1)      
Foreign currency translation adjustments 778               778  
Net loss (381,071)                 (381,071)
Preferred stock, ending balance (in shares) at Dec. 31, 2021       0            
Ending balance at Dec. 31, 2021 $ 491,554     $ 0 $ 252   876,267   688 (385,653)
Ordinary shares, ending balance (in shares) at Dec. 31, 2021 89,988,228       89,988,228          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Shares issued (in shares)         3,938,423          
Shares issued $ 37,748       $ 10   37,738      
Stock option exercises (in shares) 205,107       205,107          
Stock option exercises $ 799       $ 1   798      
Share-based compensation expense 24,965           24,965      
Vesting of ordinary shares (in shares)         853,013          
Vesting of ordinary shares 0       $ 2   (2)      
Shares withheld to pay employee withholding tax on share based compensation (in shares)         (141,380)          
Shares withheld to pay employee withholding tax on share based compensation (505)           (505)      
Foreign currency translation adjustments (2,185)               (2,185)  
Net loss (216,207)                 (216,207)
Ending balance at Dec. 31, 2022 $ 336,169       $ 265   $ 939,261   $ (1,497) $ (601,860)
Ordinary shares, ending balance (in shares) at Dec. 31, 2022 94,843,391       94,843,391